š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The objective of this study is to evaluate the comparative bioavailability ...
Status
Terminated
Location
California Clinical Trials
Start Date
2010-01
Trial ID
NCT01046214
Treatments Being Tested
This is a double-blind, placebo-controlled, randomized clinical trial evalu...
Status
Completed
Location
University of California Los Angeles (UCLA) Center for Behavioral Addiction Medicine (CBAM)
Start Date
2017-05-05
Trial ID
NCT03078075
Treatments Being Tested
Naltrexone (NTX), an opioid receptor antagonist, has a longstanding history...
Status
Recruiting
Location
Study Site
Start Date
2026-03-16
Trial ID
NCT07269873
Treatments Being Tested
To compare the rate and extent of absorption of Abrika Bupropion 150 mg XL ...
Status
Completed
Location
SFBC Ft. Myers, Inc.
Start Date
2004-06
Trial ID
NCT00863941
Treatments Being Tested
The purpose of this study is to compare the rate and extent of absorption o...
Status
Completed
Location
SFBC Ft. Myers, Inc.
Start Date
2004-07
Trial ID
NCT00865462
Treatments Being Tested
The purpose of this study is to assess the relationship between bupropion, ...
Status
Withdrawn
Location
University of California Los Angeles
Start Date
2023-06-11
Trial ID
NCT04553263
Treatments Being Tested
The aims of this study are 1) to examine the clinical utility of bupropion ...
Status
Completed
Location
Korea University Ansan Hospital
Start Date
2010-11
Trial ID
NCT01477931
Treatments Being Tested
Branded bupropion hydrochloride products including ZYBAN and WELLBUTRIN ran...
Status
Completed
Location
Multiple Locations
Start Date
2016-10-07
Trial ID
NCT03001440
Treatments Being Tested
The aim of this 2-stage, 3-site study is to investigate the effectiveness a...
Status
Completed
Location
UCLA Integrated Substance Abuse Programs
Start Date
2013-11
Trial ID
NCT01982643
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of extended...
Status
Active Not Recruiting
Location
University of Arkansas for Medical Sciences
Start Date
2024-07-01
Trial ID
NCT06233799